1. [✓] Compute sequence properties and inspect composition/topology clues  
2. [✓] Search homologs and retrieve curated functional/domain annotations  
3. [✓] Record the main findings with provenance  
4. [✓] Review the recorded evidence and provide a concise functional summary  

## Functional summary

The 404-residue protein is most likely **CoaBC, the bifunctional coenzyme A biosynthesis protein** found in bacteria.

It contains two strongly supported domains:

- **N-terminal CoaC-like phosphopantothenoylcysteine decarboxylase domain**  
  - Pfam flavoprotein domain **PF02441**, approximately residues 6–181
- **C-terminal CoaB-like phosphopantothenate–cysteine ligase domain**  
  - Pfam DFP domain **PF04127**, approximately residues 190–398

The sequence matches reviewed CoaBC proteins from *Bacillus subtilis* and *Escherichia coli* with approximately **44% identity over 92–95% of the sequence**, providing strong family-level support.

### Catalytic activities

CoaBC catalyzes two consecutive steps in CoA biosynthesis:

1. **Phosphopantothenate–cysteine ligase**  
   \[
   \text{4′-phosphopantothenate + cysteine + CTP}
   \rightarrow
   \text{4-phosphopantothenoylcysteine + CMP + pyrophosphate}
   \]
   **EC 6.3.2.5**

2. **Phosphopantothenoylcysteine decarboxylase**  
   \[
   \text{4-phosphopantothenoylcysteine}
   \rightarrow
   \text{4′-phosphopantetheine + CO₂}
   \]
   **EC 4.1.1.36**

Together, these reactions correspond to steps 2 and 3 of bacterial **coenzyme A biosynthesis**.

### Other characteristics

- Length: **404 aa**
- Estimated molecular mass: **44.3 kDa**
- Theoretical pI: **6.64**
- Likely soluble enzyme; no convincing transmembrane segment or secretion signal is apparent.
- Curated homologs bind **FMN** and require/use **Mg²⁺**.
- In *E. coli*, the homolog forms a **homododecamer**; a similar oligomeric arrangement is plausible here but is not directly demonstrated from this sequence alone.

**Overall annotation:** a bacterial, soluble, bifunctional **CoaBC enzyme involved in coenzyme A production**, with moderate-to-high confidence based on domain architecture and strong homologous sequence evidence.